Pharma News

GVK BIO Signs Definitive Agreement to Acquire Vanta Bioscience

  • Posted on: 6 November 2014
  • By: PharmaTutor News

(6th November, 2014; Business Wire India); Asia’s leading Discovery Research and Development organization, GVK BIO, announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization operating out of Chennai, India.

High-fat diet postponing brain aging in mice

  • Posted on: 6 November 2014
  • By: PharmaTutor News

(6th November, 2014); New Danish-led research suggests that signs of brain aging can be postponed in mice if placed on a high-fat diet. In the long term, this opens the possibility of treatment of children suffering from premature aging and patients with Alzheimer's and Parkinson's disease. The research project is headed by the Center for Healthy Aging, University of Copenhagen and the National Institute of Health.

Government would institutionalise a regulatory authority with full powers to oversee all-round quality standards

  • Posted on: 4 November 2014
  • By: PharmaTutor News

(4th November, 2014); Dr Harsh Vardhan, Union Health Minister, said here today that the government would institutionalise a regulatory authority with full powers to oversee all-round quality standards enforcement and consumer protection under the National Health Assurance Mission (NHAM).

Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorb® to Treat SIRS and Cardiac Surgery Patients

  • Posted on: 3 November 2014
  • By: PharmaTutor News

(3rd November, 2014; Business Wire India); Biocon Ltd, Asia's premier biopharmaceuticals company, and U.S.-based CytoSorbents Corporation (OTCQB: CTSO) announced today that they have expanded the scope of their strategic partnership for CytoSorbents’ CytoSorb® cytokine reduction therapy to treat patients experiencing severe whole body inflammation, often called a Systemic Inflammatory Response Syndrome (SIRS).  SIRS is caused by a wide range of life-threatening conditions seen in the intensive care unit and can also be caused by surgical interventions, particularly cardiac surgery.

GVK BIO Announces Successful Completion of Drug Repurposing Efforts to Identify Novel Indications

  • Posted on: 21 October 2014
  • By: PharmaTutor News

(21st October, 2014; Business Wire India); GVK Biosciences (GVK BIO) – Asia’s leading integrated Discovery Research and Development organization today announced the successful completion of in-silico based alternative indications of shelved compounds for Takeda Pharmaceutical Company Limited using GVK BIO’s proprietary Drug Repurposing Platform. Taking the project to the next level, GVK BIO and Takeda have jointly agreed to evaluate the pre-clinical proof-of-concept for certain indications of selected therapeutic compounds to develop novel indications for the previously failed compounds.

Workshop on "critical appraisal of research paper" by the Student chapter of ISPOR @ NIPER, Mohali

  • Posted on: 21 October 2014
  • By: PharmaTutor News

(21st October, 2014); The student chapter of ISPOR at NIPER, Mohali conducted a workshop on “Critical Appraisal of Research Papers” as a part of the Third International Conference of Pharmacoeconomics and Outcome Research (held on 17-18 Oct 2014 at New Delhi). Critical appraisal of literature helps in ensuring the trustworthiness, value and relevance of published research to apply into practice.

Pages